ASGE Advanced Endoscopic Lesion Resection Course (On-Demand) | November 2022-Managing Antithrombotic Therapy

Video Transcription

Video Summary

In the video, the speaker discusses the management of antithrombotic therapy, focusing on recent guidelines. They review the mechanisms of antiplatelets and anticoagulants, as well as the data on postpolypectomy bleeding risk. The speaker recommends continuing aspirin therapy for secondary prevention, despite an increased bleeding risk. For patients on P2Y12 inhibitors, including clopidogrel, there is an increased risk of bleeding, particularly delayed postpolypectomy bleeding. The speaker recommends holding these agents in patients on dual antiplatelet therapy and discusses the considerations for patients on P2Y12 inhibitor monotherapy. The speaker also discusses the management of anticoagulants, recommending the continuation of warfarin for elective endoscopy, except for advanced procedures. Heparin bridge therapy is not recommended for elective endoscopy. The speaker concludes by discussing reversal therapy for antiplatelets and anticoagulants and provides suggestions for resumption of therapy based on the type of procedure. The video does not provide information on specific credits, if any.

Asset Subtitle

Jasmine Sinha, MD, MPH

Keywords

antithrombotic therapy

recent guidelines

postpolypectomy bleeding risk

aspirin therapy

P2Y12 inhibitors

management of anticoagulants